Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Soria, A; D'Alessandro, ME; Lombardo, YB
   Duration of feeding on a sucrose-rich diet determines metabolic and morphological changes in rat adipocytes
   JOURNAL OF APPLIED PHYSIOLOGY
   
   A. Soria et al., "Duration of feeding on a sucrose-rich diet determines metabolic and morphological changes in rat adipocytes", J APP PHYSL, 91(5), 2001, pp. 2109-2116
2. Goudriaan, JR; Tacken, PJ; Dahlmans, VEH; Gijbels, MJJ; van Dijk, KW; Havekes, LM; Jong, MC
   Protection from obesity in mice lacking the VLDL receptor
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   J.R. Goudriaan et al., "Protection from obesity in mice lacking the VLDL receptor", ART THROM V, 21(9), 2001, pp. 1488-1493
3. Skrapari, I; Perrea, D; Ioannidis, I; Karabina, SAP; Elisaf, M; Tselepis, AD; Karagiannacos, P; Katsilambros, N
   Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels
   DIABETIC MEDICINE
   
   I. Skrapari et al., "Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels", DIABET MED, 18(10), 2001, pp. 781-785
4. Decombaz, J; Schmitt, B; Ith, M; Decarli, BH; Diem, P; Kreis, R; Hoppeler, H; Boesch, C
   Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects
   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
   
   J. Decombaz et al., "Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects", AM J P-REG, 281(3), 2001, pp. R760-R769
5. Goldberg, RB; Capuzzi, D
   Lipid disorders in type 1 and type 2 diabetes
   CLINICS IN LABORATORY MEDICINE
   
   R.B. Goldberg e D. Capuzzi, "Lipid disorders in type 1 and type 2 diabetes", CLIN LAB M, 21(1), 2001, pp. 147
6. van Waarde, WM; Odink, RJ; Rouwe, C; Stellaard, F; Westers, M; Vonk, RJ; Sauer, PJJ; Verkade, HJ
   Postprandial chylomicron clearance rate in late teenagers with diabetes mellitus type 1
   PEDIATRIC RESEARCH
   
   W.M. van Waarde et al., "Postprandial chylomicron clearance rate in late teenagers with diabetes mellitus type 1", PEDIAT RES, 50(5), 2001, pp. 611-617
7. Matthan, NR; Cianflone, K; Lichtenstein, AH; Ausman, LM; Jauhiainen, M; Jones, PJH
   Hydrogenated fat consumption affects acylation-stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women
   JOURNAL OF LIPID RESEARCH
   
   N.R. Matthan et al., "Hydrogenated fat consumption affects acylation-stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women", J LIPID RES, 42(11), 2001, pp. 1841-1848
8. Jong, MC; Rensen, PCN; Dahlmans, VEH; van der Boom, H; van Berkel, TJC; Havekes, LM
   Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
   JOURNAL OF LIPID RESEARCH
   
   M.C. Jong et al., "Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice", J LIPID RES, 42(10), 2001, pp. 1578-1585
9. Frenais, R; Nazih, H; Ouguerram, K; Maugeais, C; Zair, Y; Bard, JM; Charbonnel, B; Magot, T; Krempf, M
   In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: A kinetic study in control subjects and patients with type II diabetes mellitus
   JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
   
   R. Frenais et al., "In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: A kinetic study in control subjects and patients with type II diabetes mellitus", J CLIN END, 86(5), 2001, pp. 1962-1967
10. Hagstrom-Toft, E; Thorne, A; Reynisdottir, S; Mogberg, E; Rossner, S; Bolinder, J; Arner, P
    Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo
    DIABETES
    
    E. Hagstrom-Toft et al., "Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo", DIABETES, 50(7), 2001, pp. 1604-1611
11. Carpentier, A; Patterson, BW; Uffelman, KD; Giacca, A; Vranic, M; Cattral, MS; Lewis, GF
    The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism
    DIABETES
    
    A. Carpentier et al., "The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism", DIABETES, 50(6), 2001, pp. 1402-1413
12. Col, V
    New insights into insulin resistance pathophysiology: How it affects glucose and lipid metabolism
    ACTA CLINICA BELGICA
    
    V. Col, "New insights into insulin resistance pathophysiology: How it affects glucose and lipid metabolism", ACT CLIN B, 56(3), 2001, pp. 155-162
13. Raungaard, B; Brorholt-Petersen, JU; Jensen, HK; Faergeman, O
    Flow cytometric assessment of effects of fluvastatin on low-density lipoprotein receptor activity in stimulated T-lymphocytes from patients with heterozygous familial hypercholesterolemia
    JOURNAL OF CLINICAL PHARMACOLOGY
    
    B. Raungaard et al., "Flow cytometric assessment of effects of fluvastatin on low-density lipoprotein receptor activity in stimulated T-lymphocytes from patients with heterozygous familial hypercholesterolemia", J CLIN PHAR, 40(4), 2000, pp. 421-429
14. MacLean, PS; Vadlamudi, S; MacDonald, KG; Pories, WJ; Houmard, JA; Barakat, HA
    Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    P.S. MacLean et al., "Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women", METABOLISM, 49(3), 2000, pp. 285-292
15. Totsuka, M; Miyashita, Y; Ito, Y; Watanabe, H; Murano, T; Shirai, K
    Enhancement of preheparin serum lipoprotein lipase mass by bezafbirate administration
    ATHEROSCLEROSIS
    
    M. Totsuka et al., "Enhancement of preheparin serum lipoprotein lipase mass by bezafbirate administration", ATHEROSCLER, 153(1), 2000, pp. 175-179
16. Best, JD; O'Neal, DN
    Diabetic dyslipidaemia - Current treatment recommendations
    DRUGS
    
    J.D. Best e D.N. O'Neal, "Diabetic dyslipidaemia - Current treatment recommendations", DRUGS, 59(5), 2000, pp. 1101-1111
17. Bioletto, S; Golay, A; Munger, R; Kalix, B; James, RW
    Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects
    AMERICAN JOURNAL OF CLINICAL NUTRITION
    
    S. Bioletto et al., "Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects", AM J CLIN N, 71(2), 2000, pp. 443-449
18. Verges, BL
    Dyslipidaemia in diabetes mellitus - Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis
    DIABETES & METABOLISM
    
    B.L. Verges, "Dyslipidaemia in diabetes mellitus - Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis", DIABETE MET, 25, 1999, pp. 32-40
19. Shirai, K; Itoh, Y; Sasaki, H; Totsuka, M; Murano, T; Watanabe, H; Miyashita, Y
    The effect of insulin sensitizer, troglitazone, on lipoprotein lipase massin preheparin serum
    DIABETES RESEARCH AND CLINICAL PRACTICE
    
    K. Shirai et al., "The effect of insulin sensitizer, troglitazone, on lipoprotein lipase massin preheparin serum", DIABET RE C, 46(1), 1999, pp. 35-41
20. Mero, N; Suurinkeroinen, L; Syvanne, M; Knudsen, P; Yki-Jarvinen, H; Taskinen, MR
    Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant
    JOURNAL OF LIPID RESEARCH
    
    N. Mero et al., "Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant", J LIPID RES, 40(9), 1999, pp. 1663-1670
21. Srinivasan, SR; Ehnholm, C; Elkasabany, A; Berenson, G
    Influence of apolipoprotein E polymorphism on serum lipids and lipoproteinchanges from childhood to adulthood - The Bogalusa Heart Study
    ATHEROSCLEROSIS
    
    S.R. Srinivasan et al., "Influence of apolipoprotein E polymorphism on serum lipids and lipoproteinchanges from childhood to adulthood - The Bogalusa Heart Study", ATHEROSCLER, 143(2), 1999, pp. 435-443
22. Thomsen, C; Rasmussen, O; Lousen, T; Holst, JJ; Fenselau, S; Schrezenmeir, J; Hermansen, K
    Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects
    AMERICAN JOURNAL OF CLINICAL NUTRITION
    
    C. Thomsen et al., "Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects", AM J CLIN N, 69(6), 1999, pp. 1135-1143
23. HE L; FERNANDEZ ML
    DIETARY CARBOHYDRATE TYPE AND FAT-SATURATION INDEPENDENTLY REGULATE HEPATIC CHOLESTEROL AND LDL METABOLISM IN GUINEA-PIGS
    Journal of nutritional biochemistry
    
    L. He e M.L. Fernandez, "DIETARY CARBOHYDRATE TYPE AND FAT-SATURATION INDEPENDENTLY REGULATE HEPATIC CHOLESTEROL AND LDL METABOLISM IN GUINEA-PIGS", Journal of nutritional biochemistry, 9(1), 1998, pp. 37-46
24. CABEZAS MC; DEBRUIN TWA; WESTERVELD HE; MEIJER E; ERKELENS DW
    DELAYED CHYLOMICRON REMNANT CLEARANCE IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Journal of internal medicine
    
    M.C. Cabezas et al., "DELAYED CHYLOMICRON REMNANT CLEARANCE IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA", Journal of internal medicine, 244(4), 1998, pp. 299-307
25. CAIXAS A; PEREZ A; PAYES A; OTAL C; CARRERAS G; ORDONEZLLANOS J; REVIRIEGO J; ANDERSON JH; DELEIVA A
    EFFECTS OF A SHORT-ACTING INSULIN ANALOG (INSULIN LISPRO) VERSUS REGULAR INSULIN ON LIPID-METABOLISM IN INSULIN-DEPENDENT DIABETES-MELLITUS
    Metabolism, clinical and experimental
    
    A. Caixas et al., "EFFECTS OF A SHORT-ACTING INSULIN ANALOG (INSULIN LISPRO) VERSUS REGULAR INSULIN ON LIPID-METABOLISM IN INSULIN-DEPENDENT DIABETES-MELLITUS", Metabolism, clinical and experimental, 47(4), 1998, pp. 371-376
26. Mero, N; Syvanne, M; Taskinen, MR
    Postprandial lipid metabolism in diabetes
    ATHEROSCLEROSIS
    
    N. Mero et al., "Postprandial lipid metabolism in diabetes", ATHEROSCLER, 141, 1998, pp. S53-S55
27. MORENO LA; SARRIA A; QUINTELA I; BUENO M
    STANDARDIZATION OF POSTPRANDIAL LIPEMIA METHODS IN CHILDREN AND ADOLESCENTS
    NMCD. Nutrition Metabolism and Cardiovascular Diseases
    
    L.A. Moreno et al., "STANDARDIZATION OF POSTPRANDIAL LIPEMIA METHODS IN CHILDREN AND ADOLESCENTS", NMCD. Nutrition Metabolism and Cardiovascular Diseases, 7(6), 1997, pp. 481-482
28. KARPE F
    EFFECTS OF DIET ON POSTPRANDIAL LIPEMIA - A SUGGESTION FOR METHODOLOGICAL STANDARDIZATION
    NMCD. Nutrition Metabolism and Cardiovascular Diseases
    
    F. Karpe, "EFFECTS OF DIET ON POSTPRANDIAL LIPEMIA - A SUGGESTION FOR METHODOLOGICAL STANDARDIZATION", NMCD. Nutrition Metabolism and Cardiovascular Diseases, 7(1), 1997, pp. 44-55
29. STAELS B; SCHOONJANS K; FRUCHART JC; AUWERX J
    THE EFFECTS OF FIBRATES AND THIAZOLIDINEDIONES ON PLASMA TRIGLYCERIDE-METABOLISM ARE MEDIATED BY DISTINCT PEROXISOME PROLIFERATOR ACTIVATEDRECEPTORS (PPARS)
    Biochimie
    
    B. Staels et al., "THE EFFECTS OF FIBRATES AND THIAZOLIDINEDIONES ON PLASMA TRIGLYCERIDE-METABOLISM ARE MEDIATED BY DISTINCT PEROXISOME PROLIFERATOR ACTIVATEDRECEPTORS (PPARS)", Biochimie, 79(2-3), 1997, pp. 95-99
30. PEREZ A; CAIXAS A; CARRERAS G; MAURICIO D; POU JM; SERRAT J; GOMEZGERIQUE J; DELEIVA A
    LIPOPROTEIN COMPOSITIONAL ABNORMALITIES IN TYPE-I DIABETES - EFFECT OF IMPROVED GLYCEMIC CONTROL
    Diabetes research and clinical practice
    
    A. Perez et al., "LIPOPROTEIN COMPOSITIONAL ABNORMALITIES IN TYPE-I DIABETES - EFFECT OF IMPROVED GLYCEMIC CONTROL", Diabetes research and clinical practice, 36(2), 1997, pp. 83-90
31. COFFILL CR; RAMSAMY TA; HUTT DM; SCHULTZ JR; SPARKS DL
    DIACYLGLYCEROL IS THE PREFERRED SUBSTRATE IN HIGH-DENSITY-LIPOPROTEINS FOR HUMAN HEPATIC LIPASE
    Journal of lipid research
    
    C.R. Coffill et al., "DIACYLGLYCEROL IS THE PREFERRED SUBSTRATE IN HIGH-DENSITY-LIPOPROTEINS FOR HUMAN HEPATIC LIPASE", Journal of lipid research, 38(11), 1997, pp. 2224-2231
32. WESTERVELD HT; MEIJER E; ERKELENS DW; DEBRUIN TWA
    POSTPRANDIAL REDUCTION IN HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL CONCENTRATIONS IN POSTMENOPAUSAL WOMEN - IMPROVEMENT BY 17-BETA-ESTRADIOL
    Metabolism, clinical and experimental
    
    H.T. Westerveld et al., "POSTPRANDIAL REDUCTION IN HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL CONCENTRATIONS IN POSTMENOPAUSAL WOMEN - IMPROVEMENT BY 17-BETA-ESTRADIOL", Metabolism, clinical and experimental, 45(7), 1996, pp. 827-832
33. FERNANDEZ ML; VERGARAJIMENEZ M; CONDE K; ABDELFATTAH G
    DIETARY CARBOHYDRATE TYPE AND FAT AMOUNT ALTER VLDL AND LDL METABOLISM IN GUINEA-PIGS
    The Journal of nutrition
    
    M.L. Fernandez et al., "DIETARY CARBOHYDRATE TYPE AND FAT AMOUNT ALTER VLDL AND LDL METABOLISM IN GUINEA-PIGS", The Journal of nutrition, 126(10), 1996, pp. 2494-2504
34. TILLYKIESI M; KNUDSEN P; GROOP L; TASKINEN MR; NISSEN M; FORSEN B; SNICKARS B; EHRNSTROM BO; ISOMAA B; LAHTI K; FORSBLOM C; TUOMI T; LEHTO M; HAGGBLOM M; AKERMA L; EKLOF G; PAULAHARJU S; GULLSTROM M; STENBECK IB; SALMELA S; SARELIN L; HEIKKINEN S; PARKKINEN M; LAURILA E
    HYPERINSULINEMIA AND INSULIN-RESISTANCE ARE ASSOCIATED WITH MULTIPLE ABNORMALITIES OF LIPOPROTEIN SUBCLASSES IN GLUCOSE-TOLERANT RELATIVES OF NIDDM PATIENTS
    Journal of lipid research
    
    M. Tillykiesi et al., "HYPERINSULINEMIA AND INSULIN-RESISTANCE ARE ASSOCIATED WITH MULTIPLE ABNORMALITIES OF LIPOPROTEIN SUBCLASSES IN GLUCOSE-TOLERANT RELATIVES OF NIDDM PATIENTS", Journal of lipid research, 37(7), 1996, pp. 1569-1578
35. HIRANO T; NAITO H; KUROKAWA M; EBARA T; NAGANO S; ADACHI M; YOSHINO G
    HIGH PREVALENCE OF SMALL LDL PARTICLES IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS WITH NEPHROPATHY
    Atherosclerosis
    
    T. Hirano et al., "HIGH PREVALENCE OF SMALL LDL PARTICLES IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS WITH NEPHROPATHY", Atherosclerosis, 123(1-2), 1996, pp. 57-72
36. HAFFNER SM; GONZALEZ C; MIETTINEN H; HOWARD BV; STERN MP
    LDL SIZE AND SUBCLASS PATTERN IN MEXICO-CITY RESIDENTS AND SAN-ANTONIO MEXICAN-AMERICANS
    Arteriosclerosis, thrombosis, and vascular biology
    
    S.M. Haffner et al., "LDL SIZE AND SUBCLASS PATTERN IN MEXICO-CITY RESIDENTS AND SAN-ANTONIO MEXICAN-AMERICANS", Arteriosclerosis, thrombosis, and vascular biology, 15(12), 1995, pp. 2136-2141
37. BERNAL CA; GUTMAN RA; LOMBARDO YB
    THE DURATION OF FEEDING ON A SUCROSE-RICH DIET DETERMINES VARIABLE IN-VITRO EFFECTS OF INSULIN AND FRUCTOSE ON RAT-LIVER TRIGLYCERIDE-METABOLISM
    Journal of nutritional biochemistry
    
    C.A. Bernal et al., "THE DURATION OF FEEDING ON A SUCROSE-RICH DIET DETERMINES VARIABLE IN-VITRO EFFECTS OF INSULIN AND FRUCTOSE ON RAT-LIVER TRIGLYCERIDE-METABOLISM", Journal of nutritional biochemistry, 6(8), 1995, pp. 422-430
38. LAFONTAN M; LANGIN D
    CELLULAR ASPECTS OF FUEL MOBILIZATION AND SELECTION IN WHITE ADIPOCYTES
    Proceedings of the Nutrition Society
    
    M. Lafontan e D. Langin, "CELLULAR ASPECTS OF FUEL MOBILIZATION AND SELECTION IN WHITE ADIPOCYTES", Proceedings of the Nutrition Society, 54(1), 1995, pp. 49-63
39. LAU PP; CAHILL DJ; ZHU HJ; CHAN L
    ETHANOL MODULATES APOLIPOPROTEIN-B MESSENGER-RNA EDITING IN THE RAT
    Journal of lipid research
    
    P.P. Lau et al., "ETHANOL MODULATES APOLIPOPROTEIN-B MESSENGER-RNA EDITING IN THE RAT", Journal of lipid research, 36(10), 1995, pp. 2069-2078
40. FRAYN KN; KLINGMAN SM
    DIETARY SUGARS AND LIPID-METABOLISM IN HUMANS
    The American journal of clinical nutrition
    
    K.N. Frayn e S.M. Klingman, "DIETARY SUGARS AND LIPID-METABOLISM IN HUMANS", The American journal of clinical nutrition, 62(1), 1995, pp. 250-263
41. MEMON RA; FEINGOLD KR; GRUNFELD C
    THE EFFECTS OF CYTOKINES ON INTERMEDIARY METABOLISM
    The Endocrinologist
    
    R.A. Memon et al., "THE EFFECTS OF CYTOKINES ON INTERMEDIARY METABOLISM", The Endocrinologist, 4(1), 1994, pp. 56-63
42. DERGUNOV AD; ROSSENEU M
    THE SIGNIFICANCE OF APOLIPOPROTEIN-E STRUCTURE TO THE METABOLISM OF PLASMA TRIGLYCERIDE-RICH LIPOPROTEINS
    Biological chemistry Hoppe-Seyler
    
    A.D. Dergunov e M. Rosseneu, "THE SIGNIFICANCE OF APOLIPOPROTEIN-E STRUCTURE TO THE METABOLISM OF PLASMA TRIGLYCERIDE-RICH LIPOPROTEINS", Biological chemistry Hoppe-Seyler, 375(8), 1994, pp. 485-495
43. GARG A
    MANAGEMENT OF DYSLIPIDEMIA IN IDDM PATIENTS
    Diabetes care
    
    A. Garg, "MANAGEMENT OF DYSLIPIDEMIA IN IDDM PATIENTS", Diabetes care, 17(3), 1994, pp. 224-234
44. CAVALLERO E; DACHET C; NEUFCOUR D; WIRQUIN E; MATHE D; JACOTOT B
    POSTPRANDIAL AMPLIFICATION OF LIPOPROTEIN ABNORMALITIES IN CONTROLLEDTYPE-II DIABETIC SUBJECTS - RELATIONSHIP TO POSTPRANDIAL LIPEMIA AND C-PEPTIDE GLUCAGON-LEVELS
    Metabolism, clinical and experimental
    
    E. Cavallero et al., "POSTPRANDIAL AMPLIFICATION OF LIPOPROTEIN ABNORMALITIES IN CONTROLLEDTYPE-II DIABETIC SUBJECTS - RELATIONSHIP TO POSTPRANDIAL LIPEMIA AND C-PEPTIDE GLUCAGON-LEVELS", Metabolism, clinical and experimental, 43(3), 1994, pp. 270-278
45. EBARA T; HIRANO T; MAMO JCL; SAKAMAKI R; FURUKAWA S; NAGANO S; TAKAHASHI T
    HYPERLIPIDEMIA IN STREPTOZOCIN-DIABETIC HAMSTERS AS A MODEL FOR HUMANINSULIN-DEFICIENT DIABETES - COMPARISON TO STREPTOZOCIN-DIABETIC RATS
    Metabolism, clinical and experimental
    
    T. Ebara et al., "HYPERLIPIDEMIA IN STREPTOZOCIN-DIABETIC HAMSTERS AS A MODEL FOR HUMANINSULIN-DEFICIENT DIABETES - COMPARISON TO STREPTOZOCIN-DIABETIC RATS", Metabolism, clinical and experimental, 43(3), 1994, pp. 299-305
46. KATZEL LI; BUSBYWHITEHEAD J; ROGUS EM; KRAUSS RM; GOLDBERG AP
    REDUCED ADIPOSE-TISSUE LIPOPROTEIN-LIPASE RESPONSES, POSTPRANDIAL LIPEMIA, AND LOW HIGH-DENSITY LIPOPROTEIN-2 SUBSPECIES LEVELS IN OLDER ATHLETES WITH SILENT-MYOCARDIAL-ISCHEMIA
    Metabolism, clinical and experimental
    
    L.I. Katzel et al., "REDUCED ADIPOSE-TISSUE LIPOPROTEIN-LIPASE RESPONSES, POSTPRANDIAL LIPEMIA, AND LOW HIGH-DENSITY LIPOPROTEIN-2 SUBSPECIES LEVELS IN OLDER ATHLETES WITH SILENT-MYOCARDIAL-ISCHEMIA", Metabolism, clinical and experimental, 43(2), 1994, pp. 190-198
47. JEPPESEN J; ZHOU MY; CHEN YDI; REAVEN GM
    EFFECT OF GLIPIZIDE TREATMENT ON POSTPRANDIAL LIPEMIA IN PATIENTS WITH NIDDM
    Diabetologia
    
    J. Jeppesen et al., "EFFECT OF GLIPIZIDE TREATMENT ON POSTPRANDIAL LIPEMIA IN PATIENTS WITH NIDDM", Diabetologia, 37(8), 1994, pp. 781-787
48. COWIE CC; HOWARD BV; HARRIS MI
    SERUM-LIPOPROTEINS IN AFRICAN-AMERICANS AND WHITES WITH NON-INSULIN-DEPENDENT DIABETES IN THE US POPULATION
    Circulation
    
    C.C. Cowie et al., "SERUM-LIPOPROTEINS IN AFRICAN-AMERICANS AND WHITES WITH NON-INSULIN-DEPENDENT DIABETES IN THE US POPULATION", Circulation, 90(3), 1994, pp. 1185-1193
49. RUSSELL ME; WEISS KM; BUCHANAN AV; ETHERTON TD; MOORE JH; KRISETHERTON PM
    PLASMA-LIPIDS AND DIET OF THE MUSKOKE INDIANS
    The American journal of clinical nutrition
    
    M.E. Russell et al., "PLASMA-LIPIDS AND DIET OF THE MUSKOKE INDIANS", The American journal of clinical nutrition, 59(4), 1994, pp. 847-852
50. WEIGHT MJ; COETZEE HS; SMUTS CM; MARAIS MP; MARITZ JS; HOUGH FS; BENADE AJS; TALJAARD JJF
    LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY AND HIGH-DENSITY-LIPOPROTEIN SUBFRACTION COMPOSITION IN TYPE-1 DIABETIC-PATIENTS WITH IMPROVING METABOLIC CONTROL
    Acta diabetologica
    
    M.J. Weight et al., "LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY AND HIGH-DENSITY-LIPOPROTEIN SUBFRACTION COMPOSITION IN TYPE-1 DIABETIC-PATIENTS WITH IMPROVING METABOLIC CONTROL", Acta diabetologica, 30(3), 1993, pp. 159-165
51. SANE T; TASKINEN MR
    DOES FAMILIAL HYPERTRIGLYCERIDEMIA PREDISPOSE TO NIDDM
    Diabetes care
    
    T. Sane e M.R. Taskinen, "DOES FAMILIAL HYPERTRIGLYCERIDEMIA PREDISPOSE TO NIDDM", Diabetes care, 16(11), 1993, pp. 1494-1501
52. CABEZAS MC; DEBRUIN TWA; TRIP MV; KOCK LAW; JANSEN H; ERKELENS DW
    LIPOPROTEIN(A) PLASMA-CONCENTRATIONS ASSOCIATED WITH LIPOLYTIC-ACTIVITIES IN 8 KINDREDS WITH FAMILIAL COMBINED HYPERLIPIDEMIA AND NORMOLIPIDEMIC SUBJECTS
    Metabolism, clinical and experimental
    
    M.C. Cabezas et al., "LIPOPROTEIN(A) PLASMA-CONCENTRATIONS ASSOCIATED WITH LIPOLYTIC-ACTIVITIES IN 8 KINDREDS WITH FAMILIAL COMBINED HYPERLIPIDEMIA AND NORMOLIPIDEMIC SUBJECTS", Metabolism, clinical and experimental, 42(6), 1993, pp. 756-761
53. TASKINEN MR; KAHRI J; KOIVISTO V; SHEPHERD J; PACKARD CJ
    METABOLISM OF HDL APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-A-II IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
    Diabetologia
    
    M.R. Taskinen et al., "METABOLISM OF HDL APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-A-II IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS", Diabetologia, 35(4), 1992, pp. 347-356